Scarica l'app Stockscreener
0.4231
5.33%
-0.0349
Athira Pharma Inc Borsa (ATHA) Ultime notizie
Reversal indicators forming on Athira Pharma Inc. stockShort-Term Profit Alert With Entry Forecast - Newser
Sector ETF performance correlation with Athira Pharma Inc. Smart Stock Forecast Using AI Algorithms - Newser
What are Athira Pharma Inc. company’s key revenue driversCapitalize on momentum-driven investment opportunities - jammulinksnews.com
What is Athira Pharma Inc. company’s growth strategyInvest confidently with expert support - jammulinksnews.com
What makes Athira Pharma Inc. stock price move sharplyUnlock exclusive investment alerts - jammulinksnews.com
What are the latest earnings results for Athira Pharma Inc.Unprecedented growth rates - jammulinksnews.com
Published on: 2025-07-27 20:04:45 - jammulinksnews.com
Athira Pharma Inc. Earnings Report Breakdown: What Investors Should KnowFree Trading Strategy Suggestions - Newser
How Athira Pharma Inc. stock performs during market volatilitySolid Return Trade Selections - Newser
Is it the right time to buy Athira Pharma Inc. stockUnstoppable trading performance - jammulinksnews.com
Buy Signal for Athira Pharma Inc. Stock Key Technical Indicators to WatchFree Stock Market Return Analysis - Newser
Why Athira Pharma Inc. stock attracts strong analyst attentionSteady Profit Stock Forecasts - Newser
Is Athira Pharma Inc. a good long term investmentMarket-crushing profits - PrintWeekIndia
Athira Pharma Inc. Stock Analysis and ForecastUnprecedented profits - Autocar Professional
What drives Athira Pharma Inc. stock priceHigh-yield capital appreciation - jammulinksnews.com
What analysts say about Athira Pharma Inc. stockSkyrocketing investment returns - jammulinksnews.com
Athira Pharma (NASDAQ:ATHA) Trading Up 8.4% – Here’s Why - Defense World
Investors Can Still File Late Claims in Athira Pharma Settlement — Here’s How to Get Your Share - TradingView
Lewy Body Dementia Market Set to Grow Substantially Through - openPR.com
Athira Pharma (ATHA) Is Paying a $10M Settlement to Investors — Here’s How to Get Your Share - TradingView
Is Athira Pharma, Inc. technically bullish or bearish? - MarketsMojo
Two Sigma Advisers LP Has $149,000 Position in Athira Pharma, Inc. (NASDAQ:ATHA) - Defense World
ATHA LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athira Pharma, Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action – ATHA - ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Athira Pharma (NASDAQ:ATHA) Trading 9.2% Higher – Here’s Why - Defense World
HAGENS BERMAN, NATIONAL ATTORNEYS, Alerts Athira Pharma (ATHA) Investors to Filing Of Securities Class Action, Advises Investors with Losses to Contact Firm's Attorneys Now - ACCESS Newswire
Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients at the Alzheimer's Association International Conference 2022 - Barchart.com
Athira Pharma Holds Annual Stockholders Meeting - TipRanks
Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022 - Barchart.com
This Athira Pharma Insider Increased Their Holding By 111% Last Year - Yahoo Finance
Athira Pharma’s SWOT analysis: als drug developer’s stock faces pivotal phase - Investing.com
Athira Pharma (ATHA) Highlights Promising Phase 1 Results for ALS Drug Candidate | ATHA Stock News - GuruFocus
Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105 - Yahoo Finance
Athira Pharma (ATHA) Projected to Post Earnings on Wednesday - Defense World
Athira Pharma Reports Reduced Losses and Strategic Focus - MSN
Athira Pharma to Present Data from First-in-Human Phase 1 Clinic - GuruFocus
Athira Pharma to Present Data from First-in-Human Phase 1 - GlobeNewswire
0.49%
1.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):